Statin Exposure is Associated with Reduced Development of Acute-on-chronic Liver Failure in a Veterans Affairs Cohort

Overview

Journal J Clin Exp Hepatol

Publisher Elsevier

Specialty Gastroenterology

Date 2022 Nov 7

PMID 36340314

Authors

Abhinav Kumar

Affiliations

Soon will be listed here.

References

Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J . Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013; 144(7):1426-37, 1437.e1-9. DOI: 10.1053/j.gastro.2013.02.042. View

Kamal S, Khan M, Seth A, Cholankeril G, Gupta D, Singh U . Beneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2017; 112(10):1495-1505. DOI: 10.1038/ajg.2017.170. View

Wang Y, Wang W, Wang M, Shi J, Jia X, Dang S . A Meta-Analysis of Statin Use and Risk of Hepatocellular Carcinoma. Can J Gastroenterol Hepatol. 2022; 2022:5389044. PMC: 8958112. DOI: 10.1155/2022/5389044. View

Bjornsson E . Hepatotoxicity of statins and other lipid-lowering agents. Liver Int. 2016; 37(2):173-178. DOI: 10.1111/liv.13308. View

. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994; 344(8934):1383-9. View

Schierwagen R, Uschner F, Magdaleno F, Klein S, Trebicka J . Rationale for the use of statins in liver disease. Am J Physiol Gastrointest Liver Physiol. 2017; 312(5):G407-G412. DOI: 10.1152/ajpgi.00441.2016. View

Kaplan D, Dai F, Aytaman A, Baytarian M, Fox R, Hunt K . Development and Performance of an Algorithm to Estimate the Child-Turcotte-Pugh Score From a National Electronic Healthcare Database. Clin Gastroenterol Hepatol. 2015; 13(13):2333-41.e1-6. PMC: 4655141. DOI: 10.1016/j.cgh.2015.07.010. View

Singh S, Paul Singh P, Singh A, Murad M, Sanchez W . Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis. Gastroenterology. 2012; 144(2):323-332. DOI: 10.1053/j.gastro.2012.10.005. View

Abraldes J, Albillos A, Banares R, Turnes J, Gonzalez R, Garcia-Pagan J . Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial. Gastroenterology. 2009; 136(5):1651-8. DOI: 10.1053/j.gastro.2009.01.043. View

10.

Shepherd J, Cobbe S, Ford I, Isles C, LORIMER A, Macfarlane P . Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995; 333(20):1301-7. DOI: 10.1056/NEJM199511163332001. View

11.

Kasia C, Scaglione S . Patients With Chronic Liver Disease/Cirrhosis Should Not Take Statin Medications. Clin Liver Dis (Hoboken). 2019; 13(4):106-110. PMC: 6491028. DOI: 10.1002/cld.788. View

12.

Munoz A, Pollarsky F, Marino M, Cartier M, Miguez C, Vazquez H . Safety of Chronic Simvastatin Treatment in Patients with Decompensated Cirrhosis: Many Adverse Events but No Liver Injury. Dig Dis Sci. 2020; 66(9):3199-3208. DOI: 10.1007/s10620-020-06630-7. View

13.

Sterling R, Lissen E, Clumeck N, Sola R, Correa M, Montaner J . Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006; 43(6):1317-25. DOI: 10.1002/hep.21178. View

14.

Deshpande A, Pasupuleti V, Rothberg M . Statin therapy and mortality from sepsis: a meta-analysis of randomized trials. Am J Med. 2014; 128(4):410-7.e1. DOI: 10.1016/j.amjmed.2014.10.057. View

15.

Kaplan D, Mehta R, Garcia-Tsao G, Albrecht J, Aytaman A, Baffy G . SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation. Contemp Clin Trials. 2021; 104:106367. PMC: 8422958. DOI: 10.1016/j.cct.2021.106367. View